These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36774159)

  • 1. Conventional and Novel Approaches to Immunosuppression in Lung Transplantation.
    Patterson CM; Jolly EC; Burrows F; Ronan NJ; Lyster H
    Clin Chest Med; 2023 Mar; 44(1):121-136. PubMed ID: 36774159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches for long-term lung transplant survival.
    Miller CL; O JM; Allan JS; Madsen JC
    Front Immunol; 2022; 13():931251. PubMed ID: 35967365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression and rejection in human hand transplantation.
    Schneeberger S; Gorantla VS; Hautz T; Pulikkottil B; Margreiter R; Lee WP
    Transplant Proc; 2009 Mar; 41(2):472-5. PubMed ID: 19328906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression for lung transplantation.
    Ng CY; Madsen JC; Rosengard BR; Allan JS
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1627-41. PubMed ID: 19273152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression: practice and trends.
    Kaufman DB; Shapiro R; Lucey MR; Cherikh WS; T Bustami R; Dyke DB
    Am J Transplant; 2004; 4 Suppl 9():38-53. PubMed ID: 15113354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression in Lung Transplantation.
    Nelson J; Kincaide E; Schulte J; Hall R; Levine DJ
    Handb Exp Pharmacol; 2022; 272():139-164. PubMed ID: 34796380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on immunosuppressive strategies in intestinal transplantation.
    Merola J; Shamim A; Weiner J
    Curr Opin Organ Transplant; 2022 Apr; 27(2):119-125. PubMed ID: 35232925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression for lung transplantation.
    Bhorade SM; Stern E
    Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Evolution of Lung Transplant Immunosuppression.
    Ivulich S; Westall G; Dooley M; Snell G
    Drugs; 2018 Jul; 78(10):965-982. PubMed ID: 29915895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression Withdrawal After Liver Transplantation for Common Variable Immunodeficiency.
    Detry O; Meurisse N; Jouret F; Bletard N; Delwaide J; Moutschen M
    Liver Transpl; 2021 Feb; 27(3):456-458. PubMed ID: 32810897
    [No Abstract]   [Full Text] [Related]  

  • 11. New developments in treatment after lung transplantation.
    Benden C; Danziger-Isakov L; Faro A
    Curr Pharm Des; 2012; 18(5):737-46. PubMed ID: 22283768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression for lung transplantation.
    Allan JS
    Semin Thorac Cardiovasc Surg; 2004; 16(4):333-41. PubMed ID: 15635537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation.
    Campa-Carranza JN; Paez-Mayorga J; Chua CYX; Nichols JE; Grattoni A
    Expert Opin Drug Deliv; 2022 May; 19(5):595-610. PubMed ID: 35588058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation.
    Nelson J; Alvey N; Bowman L; Schulte J; Segovia MC; McDermott J; Te HS; Kapila N; Levine DJ; Gottlieb RL; Oberholzer J; Campara M
    Pharmacotherapy; 2022 Aug; 42(8):599-633. PubMed ID: 36032031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance immunosuppression in the renal transplant recipient: an overview.
    Gaston RS
    Am J Kidney Dis; 2001 Dec; 38(6 Suppl 6):S25-35. PubMed ID: 11729003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and International Society for Heart and Lung Transplantation: An executive summary.
    Nelson J; Alvey N; Bowman L; Schulte J; Segovia MC; McDermott J; Te HS; Kapila N; Levine DJ; Gottlieb RL; Oberholzer J; Campara M
    Pharmacotherapy; 2022 Aug; 42(8):594-598. PubMed ID: 35810342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New immunosuppressive agents in pediatric transplantation.
    Nguyen C; Shapiro R
    Clinics (Sao Paulo); 2014; 69 Suppl 1(Suppl 1):8-16. PubMed ID: 24860853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving immunosuppressive regimens for lung transplant recipients.
    Meyer NJ; Bhorade SM
    Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression and Kidney Transplantation.
    Kamal J; Doyle A
    Handb Exp Pharmacol; 2022; 272():165-179. PubMed ID: 34697664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.